N-Xime 100 Tablet DT contains Cefixime 100 mg, a third-generation cephalosporin antibiotic with broad-spectrum activity against various Gram-positive and Gram-negative bacteria. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains. Cefixime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible form, allowing for ease of administration, especially in pediatric and geriatric patients who may have difficulty swallowing conventional tablets. N-Xime 100 Tablet DT demonstrates good oral bioavailability and achieves therapeutic concentrations in blood and tissues. It is generally well-tolerated, with the most common adverse effects including gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of resistance. N-Xime 100 Tablet DT should be used under medical supervision with appropriate microbiological guidance.